BioCorRx (OTCMKTS:BICX) Issues Quarterly Earnings Results

BioCorRx (OTCMKTS:BICX) announced its quarterly earnings results on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports.

BioCorRx Price Performance

OTCMKTS BICX opened at $0.48 on Wednesday. BioCorRx has a 12 month low of $0.26 and a 12 month high of $1.50. The stock has a market capitalization of $7.70 million, a P/E ratio of -0.92 and a beta of 0.57. The firm’s 50-day moving average is $0.39 and its two-hundred day moving average is $0.37.

About BioCorRx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.